References
1. Armstrong WB, Vokes DE, Maisel RH. Malignant tumors of the larynx.Cummings otolaryngology head and neck surgery ed t, editor:
Philadelphia: Mosby elsevier. 2010:1482-1511.
2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A.
Global cancer statistics 2018: GLOBOCAN estimates of incidence and
mortality worldwide for 36 cancers in 185 countries. CA: a cancer
journal for clinicians. 2018;68(6):394-424.
3. Coleman MP, Esteve J, Damiecki P, Arslan A, Renard H. Trends in
cancer incidence and mortality. IARC scientific publications.1993(121):1-806.
4. Warner L, Chudasama J, Kelly CG, et al. Radiotherapy versus open
surgery versus endolaryngeal surgery (with or without laser) for early
laryngeal squamous cell cancer. Cochrane Database of Systematic
Reviews. 2014(12).
5. Agarwal JP, Baccher GK, Waghmare CM, et al. Factors affecting the
quality of voice in the early glottic cancer treated with radiotherapy.Radiotherapy and Oncology. 2009;90(2):177-182.
6. Bibby JR, Cotton SM, Perry A, Corry JF. Voice outcomes after
radiotherapy treatment for early glottic cancer: assessment using
multidimensional tools. Head & Neck: Journal for the Sciences and
Specialties of the Head and Neck. 2008;30(5):600-610.
7. Fung K, Lyden TH, Lee J, et al. Voice and swallowing outcomes of an
organ-preservation trial for advanced laryngeal cancer.International Journal of Radiation Oncology* Biology* Physics.2005;63(5):1395-1399.
8. Hecker MH, Kreul EJ. Descriptions of the speech of patients with
cancer of the vocal folds. Part I: Measures of fundamental frequency.The Journal of the Acoustical Society of America.1971;49(4B):1275-1282.
9. Collaboration SMa. Adjuvant chemotherapy for localised resectable
soft tissue sarcoma in adults. Cochrane Database of Systematic
Reviews. 2000(4).
10. Kim JP, Kim JY, Ko GH, Woo SH. A rare case of malignant fibrous
histiocytoma (pleomorphic undifferentiated sarcoma NOS) of the vocal
fold. Ear, Nose & Throat Journal. 2015;94(7):270-272.
11. Pathrose G, John NT, Manojkumar R. A rare case of malignant fibrous
histiocytoma/pleomorphic undifferentiated sarcoma of the kidney.Journal of Clinical and Diagnostic Research: Jcdr.2015;9(1):PD27.
12. Peng KA, Grogan T, Wang MB. Head and neck sarcomas: analysis of the
SEER database. Otolaryngology–Head and Neck Surgery.2014;151(4):627-633.
13. Zagars GK, Ballo MT, Pisters PW, et al. Prognostic factors for
patients with localized soft‐tissue sarcoma treated with conservation
surgery and radiation therapy: an analysis of 1225 patients.Cancer: Interdisciplinary International Journal of the American
Cancer Society. 2003;97(10):2530-2543.
14. Ługowska I, Raciborska A, Kiprian D, et al. Recommendations in
management of head and neck sarcomas. Oncology in Clinical
Practice. 2018;14(6):295-301.
15. Cates JM. Performance analysis of the American Joint Committee on
Cancer 8th edition staging system for retroperitoneal sarcoma and
development of a new staging algorithm for sarcoma-specific survival.Annals of surgical oncology. 2017;24(13):3880-3887.
16. Forastiere AA, Ismaila N, Lewin JS, et al. Use of
larynx-preservation strategies in the treatment of laryngeal cancer:
American Society of Clinical Oncology clinical practice guideline
update. Journal of Clinical Oncology. 2018;36(11):1143-1169.
Figure 1 - Coronal and Axial Neck CT with contrast
Figure 2 - Intraoperative image of the mass as appears under
micro-laryngoscopy
Figure 3 - Low power view of the
tumor composed of pleomorphic malignant spindle cells. Note the
overlying non-atypical squamous mucosa on the top right aspect of the
image (H and E x 10)
Figure 4 - High power view of the tumor showing marked nuclear
pleomorphism with frequent mitoses (black arrow) (H and E x 40)